Navigation Links
GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer
Date:12/11/2009

TYKERB plus capecitabine compared to capecitabine alone were diarrhea (65%, 40%), nausea (44%, 43%), vomiting (26%, 21%), palmar-plantar erythrodysesthesia (53%, 51%), rash (28%, 14%), and fatigue (46%, 47%).

The most common grade 3 and 4 adverse reaction (NCICTC v3) with TYKERB plus capecitabine compared to capecitabine alone were diarrhea (14%, 10%) and palmar-plantar erythrodysesthesia (12%, 14%).

Please see full prescribing information, including BOXED WARNING.

Notes to Editors:

TYKERB® is a registered trademark of the GlaxoSmithKline group of companies in the United States.

TYVERB® is a registered trademark of the GlaxoSmithKline group of companies in Europe.

XELODA® is a registered trademark of Roche Laboratories Inc.

HERCEPTIN® is a registered trademark of Genentech, Inc.



    Enquiries:
    Onsite Media Enquiries (US Media)     Ken Inchausti         (267) 809 7552
    Onsite Media Enquiries (ex-US Media)  Gregory Clarke        (610) 405 0053

    UK Media Enquiries:                   Philip Thomson       (020) 8047 5502
                                          David Outhwaite      (020) 8047 5502
                                          Stephen Rea          (020) 8047 5502

    US Media Enquiries:                   Nancy Pekarek         (919) 483 2839
                                          Mary Anne Rhyne       (919) 483 2839
                                          Kevin Colgan          (919) 483 2839
                                          Sarah Alspach         (919) 483 2839

    European Analyst/Investor Enquiries:  David Mawdsley       (020) 8047 5564
                                          Sally Ferguson       (020) 8047 5543
                                          Gary Davies          (020) 8047 5503

    US Analyst/Investor Enquiries:        Tom Curry             (215) 751 5419
                                        
'/>"/>
SOURCE  GlaxoSmithKline
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 

Related medicine technology :

1. Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy
2. Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer
3. DecisionView Launches StudyOptimizer(TM) 4
4. Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection
5. OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months
6. Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock
7. Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium
8. Final Data from Phase 2 Study Confirm High Response Rate of Micromets Blinatumomab in Patients with Acute Lymphoblastic Leukemia
9. Hemodynamic Therapeutics Announces Successful Completion of Initial Phase 2 Clinical Study for Novel Combination Hypertension Therapy
10. Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP
11. ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-ENs Effectiveness in Maintaining Remission in Patients with Crohns Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 2013 The power of plants to cure ... which mankind depends on the plant kingdom, is the ... Wild Medicine: Healing Plants Around the ... from May 18 through September 8, 2013. ... exhibition,s many attractions include a re-creation of the Western ...
(Date:5/17/2013)... -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) today announced ... Global Healthcare Conference in New York . ... at 11 a.m. Eastern Time. To listen to the live ... Investor Relations section of the Company,s Web site at ... after the event. About Orexigen® Therapeutics Orexigen ...
(Date:5/17/2013)... 17, 2013  Sony Biotechnology Inc. ("Sony") today announced ... (SP6800).  Sony will be exhibiting and taking orders for ... at the San Diego Convention ... from May 20 - 22.  The ... commercial audio-visual technologies into new and novel functionalities for ...
Breaking Medicine Technology:Wild Medicine On View at The New York Botanical Garden Through Sept. 8 2Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2
... /PRNewswire-Asia/ -- Recently, Wang Qiao, the eight-year program student ... tutored under Yan Lynan, went to San Francisco to ... meeting with the director of his department, Mr. Li ... The theme of the meeting is "The Pros ...
...  Marken announced today that it has opened its first ... service operations and offer local service to its customers ... operates in the country through its partners, managing thousands ... country.  This new office has been created recognizing that ...
Cached Medicine Technology:Student of Liver And Vascular Surgery of West China Hospital of Sichuan University Addresses The 18th ILTS Annual Meeting in the United States 2Marken Opens Branch Office In Seoul, South Korea 2
(Date:5/18/2013)... 18, 2013 As metal-on-metal hip ... the country, Bernstein Liebhard LLP notes that a new ... suffer tissue damage before they experience any pain from ... Science Daily will appear in the Journal of Bone ... MRI screens of their hips. The researchers found ...
(Date:5/18/2013)... 18, 2013 Although obesity is associated ... association between obesity and esophageal adenocarcinoma, a type of ... tumors. As reported on Cancer.gov, last reviewed ... twice as likely as those of normal and healthy ... between obesity and esophageal cancer is not well understood, ...
(Date:5/18/2013)... The “Sleep Apnea Diagnostic & Therapeutic Devices Market [Polysomnographs, ... Oral Appliances, Nasal EPAP, Neurostimulation] Global End-user Analysis, Competitive ... major market drivers, restraints, and opportunities in North America, ... , 147 market data tables ... 318 pagesand in-depth TOC of “Sleep Apnea ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 Adolescents, especially ... known as “Spice” or “K2” are landing in emergency ... to curb this drug epidemic with a new ... marijuana. , According to research from the National Institute ... popular illegal drug among American teenagers. In 2012, 11 ...
(Date:5/18/2013)... Mexico, DF (PRWEB) May 18, 2013 ... by leading ayurvedic education institution in the West. Program ... Learning education. , Ayurveda is a healing modality practiced ... Ayurvedica ), it is considered that health begins when ... a profound understanding of their individual needs. Ayurveda aims ...
Breaking Medicine News(10 mins):Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 2Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 3Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 4Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 2Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 3Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 2Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 3Health News:Spice Addiction Treatment and Synthetic Marijuana Drug Rehab Announced by Recovery Associates 2Health News:Ayurveda Training in Mexico Offered by Escuela de Ayurveda de California, a Leading Institution in the West 2
... Center scientists are presenting research today on a more ... been unresponsive to current// drug therapies. ... Infergen, a highly potent Interferon, is nearly twice as ... are sharing their findings at the annual American Association ...
... confusing. And most of us can recall having difficulty ... you have stopped taking a// prescription too soon because ... prevents you from accurately reading the label on the ... of good health care. ,Communication problems with ...
... pink race gear on e Bay in favor of Susan ... Awareness month and pink is// the symbolic color of Breast ... Racing to create exclusive warriors in pink livery with exclusive ... the eBay auction. ,Parts of the Warrior in ...
... that result in almost 34,000 deaths a year in hospitals ... Healthcare Commission which inspects the NHS.// The independent health watchdog ... priority for the NHS. ,Although the exact ... known completely previous studies have estimated it is up to ...
... Turmeric the must have spice in every Indian home now ... its potential uses to fight// many tubborn inflammations and degenerative ... the ancient scripts of Ayurveda. ,According to a ... Medicine by Janet L. Funk, MD, working with Barbara N. ...
... ridden NHS hospital's radiotherapy department to dogs and cats ailing ... , ,To effectively manage the ?24m debt at Ipswich ... a pets’ clinic could be instituted on Saturdays to put ... with the huge debt. According to the calculations made ...
Cached Medicine News:Health News:Making Headway Against Hepatitis C 2Health News:Low Health Literacy Interferes with Good Health Care 2Health News:Patient Safety Not Addressed by NHS 2Health News:Patient Safety Not Addressed by NHS 3Health News:Pet Peeves: Conservatives Howl at Proposal to Share NHS Hosp by Pets and People 2
... Perimeter utilizes Welch Allyn Frequency Doubling ... in visual field testing by combining ... characterize glaucoma and basic glaucoma management ... the Matrix doubles as an in-office ...
... IMAGE1 is the first completely digital ... first in the field of endoscopic camera ... for the first time, facilitates the fully ... in quality using an A/D converter, as ...
... It has long been ... evacuation to be used during ... the healthcare industry contend that ... procedures is as harmful as ...
Erbium Laser with Sapphire Erbium Handpiece for Dermatological and Cosmetic Surgery...
Medicine Products: